GHOSTS OF HOLIDAY SEASONS PAST — State health officials are concerned that a unique mix of viral outbreaks could make for a hard holiday season, Megan reports . Public health experts are urging people to get vaccinated against the flu and Covid-19 before gathering with friends and family for the holidays. Even though some experts think this winter’s Covid surge could be mild compared with the last two, flu, Covid and respiratory syncytial virus outbreaks — along with existing staffing shortages — could stretch facilities beyond their capacities, leaders worry. It highlights an ongoing effort from health leaders to get Americans vaccinated and remind them of the health system’s limits. “Most of the population — unfortunately — has forgotten about Covid-19 and moved on. As a result, we’re seeing a rise in cases and a rise in hospitalizations, and that worries me,” said Ali Mokdad, professor of global health at the Institute for Health Metrics and Evaluation at the University of Washington told POLITICO. “Right now, with the rise of flu, RSV and Covid, our health professionals are exhausted.” For some providers, this winter doesn’t seem that different from the pandemic’s early days when health systems were overwhelmed by the new virus. Now, Mississippi is down to 65 ICU beds and transferring some patients to other states, though Tennessee and Alabama have stopped accepting out-of-state transfers. Hospital networks are asking the federal government for additional resources, and Oregon Gov. Kate Brown signed an executive order Wednesday in response to outbreaks. Much of the U.S. seems to have moved on from measures intended to protect public health, but the mix of rising infections could continue to press health workers through the winter. Health experts are hopeful a growing immunity will protect people — particularly those who are older or have compromised immune systems and would be at heightened risk. “It’s not just the challenge of Covid-19; it’s influenza and RSV stacked on top of Covid that’s presenting a challenge to our health care system,” Rachel Herlihy, Colorado’s state epidemiologist, said. WELCOME TO MONDAY PULSE, where we learned that being optimistic about an outcome could actually change it — at least when it comes to placebos in cannabinoid pain relief trials . We’re hoping the same positive outlook could work for how long Congress will be negotiating a year-end deal. Know anything about how that’s coming along? Drop us a line at dpayne@politico.com and kmahr@politico.com . TODAY ON OUR PULSE CHECK PODCAST , Megan Messerly talks with Lauren Gardner about the introduction next year of biosimilars that will compete with the arthritis medication Humira, the best-selling drug in America, once it goes off-patent.
|